Cherokee Custom Script Pharm is categorized under in Canton, GA and active since 2012.
Cherokee Custom Script Pharm was established in 2012, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a business, which does work in the B2C market, and is classified as a , under code number 4461100 by the NAICS.
If you are seeking more information, feel free to contact Dale Coker, Owner at the company’s single location by writing to 2260 Holly Springs Parkway # 180, Canton, Georgia GA 30115 or by phoning (770) 704-6161. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cherokee Custom Script Pharm |
| Contact Person: | Dale Coker, Owner |
| Address: | 2260 Holly Springs Parkway # 180, Canton, Georgia 30115 |
| Phone Number: | (770) 704-6161 |
| Website Address: | cherokeecustomrx.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | |
| SIC Code: | 5912 |
| NAICS Code: | 4461100 |
| Share This Business: |
Cherokee Custom Script Pharm was started in 2012 to provide professional under the SIC code 5912 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Dale Coker, Owner for inquiries that concern Cherokee Custom Script Pharm by calling the company number (770) 704-6161, as your correspondence is most welcome. Additionally, the physical location of the single location of Cherokee Custom Script Pharm can be found at the coordinates 34.17964,-84.50374 as well as the street address 2260 Holly Springs Parkway # 180 in Canton, Georgia 30115.
For its online presence, you may visit Cherokee Custom Script Pharm’s website at cherokeecustomrx.com and engage with its social media outlets through on Twitter and on Facebook.